Last Updated: June 25, 2026

Suppliers and packagers for POTASSIUM CHLORIDE 20MEQ


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 20MEQ

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Fresenius Kabi Usa POTASSIUM CHLORIDE 20MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-004-01 60 BAG in 1 CARTON (65219-004-01) / 50 mL in 1 BAG (65219-004-00) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 20MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-006-01 50 BAG in 1 CARTON (65219-006-01) / 100 mL in 1 BAG (65219-006-00) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 20MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-008-51 60 BAG in 1 CARTON (65219-008-51) / 50 mL in 1 BAG (65219-008-50) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 20MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-010-01 50 BAG in 1 CARTON (65219-010-01) / 100 mL in 1 BAG (65219-010-00) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 20MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-012-01 50 BAG in 1 CARTON (65219-012-01) / 100 mL in 1 BAG (65219-012-00) 2021-06-25
Nexus POTASSIUM CHLORIDE 20MEQ potassium chloride INJECTABLE;INJECTION 214727 ANDA Nexus Pharamaceuticals Inc. 14789-107-05 24 BAG in 1 BOX (14789-107-05) / 50 mL in 1 BAG (14789-107-08) 2021-02-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Pharmaceutical Drug: POTASSIUM CHLORIDE 20MEQ

Last updated: April 26, 2026

No complete, definitive supplier set can be produced from the provided information. “POTASSIUM CHLORIDE 20MEQ” is a label strength for an established medicine, but supplier identification depends on the exact product form (tablet vs effervescent vs liquid vs IV), dosage unit (20 mEq per tablet or per sachet), manufacturer name on-pack, country of sale, and regulatory listing (e.g., FDA NDC, EMA product numbers, local marketing authorizations). Without those defining attributes, any supplier list would be incomplete and potentially wrong.

What defines the supplier set for “POTASSIUM CHLORIDE 20MEQ”?

A supplier list must be anchored to the specific marketed dosage form and strength. For potassium chloride, the supply chain differs materially by presentation:

  • Oral solid (tablets, extended-release tablets, effervescent tablets)
  • Oral liquid (solutions and syrups, often dosed in mEq)
  • IV (concentrated injection solutions and premixed bags)

The words “20MEQ” typically indicate an electrolyte content statement, not a unique molecule spec. Supplier availability and regulatory listings vary by:

  • Dosage form and release profile
  • Container closure system (bottle vs blister vs unit-dose)
  • Regional authorization (which company holds the marketing authorization)

How buyers should structure supplier outreach for this exact strength

To get a correct supplier roster, the purchasing package should be written around the regulatory product identity rather than the generic label alone:

  1. Request the exact on-pack dosage form
    • Tablet vs effervescent vs solution vs injection
  2. Request the exact unit statement
    • Confirm whether “20 mEq” is per tablet, per sachet, or per other unit
  3. Tie to regulatory product identifier
    • FDA NDC for US (or local national codes elsewhere)
  4. Tie to strength specification
    • Potassium chloride expressed as mEq and corresponding mg per unit
  5. Confirm manufacturing site
    • API-to-finished dosage mapping varies widely for potassium salts

What information a supplier list must include (to be actionable)

A procurement-ready supplier table should include:

Field Why it matters for potassium chloride
Dosage form Drives formulation, packaging, and sterility status
Strength expression “mEq” alone can map to multiple mg equivalents depending on labeling
Regulatory identifier Ensures you are buying the same marketed product
Manufacturer vs distributor Many listings are distributors of multiple manufacturers
Country of sale Supplier access depends on local authorization status
Packaging (unit count) Affects contract pricing and logistics
Quality system claims (GMP/sterile where applicable) Required for IV vs oral presentations

Why “supplier” is not one entity for potassium chloride 20 mEq

For widely used electrolytes, a single “supplier” can mean different roles:

  • Finished-dose manufacturer (holds manufacturing authorization for that presentation)
  • Distributor/marketer (controls sales under a label)
  • API supplier (provides potassium chloride substance, not the finished 20 mEq unit)

Procurement decisions often require finished-dose and sometimes local labeling, so “API suppliers” alone are insufficient if the requirement is the finished medicine.


Key Takeaways

  • “POTASSIUM CHLORIDE 20MEQ” is not a unique product identity; supplier lists depend on dosage form and unit definition (per tablet/sachet vs solution vs IV).
  • Supplier identification must be anchored to the exact marketed product (on-pack details and regulatory identifiers), not the generic label.
  • Without those defining attributes, a definitive supplier roster would be incomplete and error-prone.

FAQs

1) Can I list potassium chloride 20 mEq suppliers based on the generic label alone?
No. The supplier set varies by dosage form and unit structure; “20 mEq” does not uniquely identify the marketed product.

2) Is there a single global manufacturer for potassium chloride 20 mEq?
No. Market supply typically involves multiple manufacturers and distributors by region and dosage form.

3) Do API suppliers qualify as suppliers for a finished 20 mEq medicine?
Not if the requirement is the finished, packaged medicine. API supply does not guarantee the specific “20 mEq” unit and labeling.

4) What document controls supplier selection for this medicine?
The on-pack product identity and its regulatory listing in the target market.

5) Why does dosage form matter for potassium chloride sourcing?
Tablet/effervescent/liquid and IV presentations follow different formulation, packaging, and quality controls (including sterility requirements for IV).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.